Monitoring Blood Pressure at Home and Pharmacy Telehealth
REMAP-BP
REmote Blood Pressure Monitoring and Pharmacist-Led Telehealth Program in an Emergency Department Transitional Care Clinic
2 other identifiers
interventional
420
1 country
1
Brief Summary
The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage your blood pressure is useful. The study will enroll 400 participants who are seen at the University of Alabama at Birmingham Emergency Department - Transitional Care Clinic and Tampa General Hospital -Transitional Care Clinic. Half of the participants (200 patients) will be asked to measure their blood pressure at home, and half of the participants (200 patients) will continue to receive usual care. Participants who measure their blood pressure at home will also meet with a pharmacist weekly over the phone to discuss blood pressure readings and have blood pressure medications prescribed if needed. This program will last 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Apr 2027
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2026
CompletedFirst Posted
Study publicly available on registry
June 3, 2026
CompletedStudy Start
First participant enrolled
April 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2031
Study Completion
Last participant's last visit for all outcomes
January 1, 2031
June 3, 2026
May 1, 2026
3.8 years
May 28, 2026
May 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Number of Enrolled Participants with Blood Pressure Control
The number of enrolled participants with blood pressure control
12 weeks (3 months) from randomization
Secondary Outcomes (1)
Number of Participants in the Intervention with Patient-Reported Outcomes
24 weeks (6 months) from randomization
Study Arms (2)
Usual Care
PLACEBO COMPARATORParticipants receive usual care from providers to manage their blood pressure
Remote Blood Pressure Monitoring + Telehealth
ACTIVE COMPARATORParticipants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management
Interventions
Participants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- Ability to speak English
- Seen at UAB's or TGH's Emergency Department-Transitional Care Clinic
- Blood pressure at Emergency Department-Transitional Care Clinic: Systolic BP ≥ 130 mmHg or Diastolic BP ≥ 80 mmHg
- Have a cellphone with video capability
You may not qualify if:
- Lack of willingness or inability to provide written informed consent
- Individuals who work overnight or second shift
- History of known major arrhythmias
- Currently pregnant or breastfeeding
- Arm circumference \>50 cm. \*The upper limit for the largest BP cuff for oscillometric BP devices is typically 50-52 cm; data from the National Health and Nutrition Examination Survey, 2011-2016 indicated that \<1% of US adults have an arm circumference \>50 cm, so this will have minimal effect on our study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lama Ghazi, MD, PhD
University of Alabama at Birmingham
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
May 28, 2026
First Posted
June 3, 2026
Study Start (Estimated)
April 1, 2027
Primary Completion (Estimated)
January 1, 2031
Study Completion (Estimated)
January 1, 2031
Last Updated
June 3, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
While we do not anticipate generating research tools, we are committed to adhering to the National Institutes of Health (NIH) Research Tools Policy to ensure that any resources developed under this award are readily available to qualified researchers. If an NIH-defined research tool is developed, we will collaborate with University of Alabama at Birmingham Commercialization and Licensing Office and all participating institutions to define ownership, protect intellectual property, and establish a dissemination strategy that ensures appropriate access and compliance with NIH guidelines.